Akba stock after hours

Apr 03, 2020 · The options have an exercise price of $7.58 per share, which is equal to the closing price of Akebia's common stock on the grant date. About Akebia TherapeuticsAkebia Therapeutics (AKBA), Inc. is a fully integrated biopharmaceutical company focused on the development and commercialization of therapeutics for people living with kidney disease. Akebia Therapeutics Inc. Research & Ratings (AKBA) | Barron's Mar 27, 2020 · View today's stock price, news and analysis for Akebia Therapeutics Inc. (AKBA). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation

Akebia Therapeutics (NASDAQ:AKBA) Ratings | Benzinga Jan 01, 2010 · Akebia Therapeutics (NASDAQ: AKBA) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on Why Akebia Therapeutics Stock Is Jumping Today | The ... Shares of Akebia Therapeutics (NASDAQ:AKBA) were jumping 10.3% higher as of 11:28 a.m. EST on Friday after rising as much as 18.2% earlier in the morning. The biotech didn't announce any new AKBA Stock Price and Chart — NASDAQ:AKBA — TradingView — … TradingView India. View live AKEBIA THERAPEUTICS INC chart to track its stock's price action. Find market predictions, AKBA financials and market news. After-Hours Stock Movers 05/15: (AKBA) (ETSY) (BDSI ...

Real-time trade and investing ideas on Akebia Therapeutics AKBA from the largest community of traders and investors. ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal.

Find the latest Akebia Therapeutics, Inc. (AKBA) stock quote, history, news and other vital information to help you with your stock trading and investing. AKBA Stock Quote - Akebia Therapeutics, Inc. Stock Price Today Akebia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with kidney disease. The firm also involves in the development and commercialization of drugs for the treatment of renal and metabolic disorders. Its products include Auryxia and Vadadustat. AKBA - Stock quote for AKEBIA THERAPEUTICS, INC. - MSN Money View the latest AKBA stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of AKEBIA THERAPEUTICS, INC..

Why Akebia Therapeutics, Inc. (AKBA) Shares Are Dropping ...

Akebia Therapeutics Inc Stock Quote: AKBA Stock News ... Nov 06, 2019 · AKBA, Akebia Therapeutics Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines How to Buy Stocks After Hours | Finance - Zacks How to Buy Stocks After Hours. By: Chirantan Basu . Review the fundamentals because buying a stock after-hours is the same as buying it in the regular trading session. For example, if a Akebia Therapeutics, Inc. - AKBA - Stock Price Today - Zacks View Akebia Therapeutics, Inc. AKBA investment & stock information. Get the latest Akebia Therapeutics, Inc. AKBA detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

AKBA's NASDAQ Last Sale (NLS) "Last Sale" is the price at which a stock last traded during regular market hours. NLS Volume "Volume" is the number of shares of the stock traded on the listing exchange during regular trading hours. Previous Close Today's High / Low 52 Week High / Low

AKBA, Akebia Therapeutics Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Investor's Business Daily 01/28/2016 04:30 PM ET  Get today's Akebia Ther stock price and latest AKBA news as well as Akebia Ther PETX, ZAGG, IRWD and INSM among notable after hour movers By Seeking  24 Feb 2020 Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company A replay of the conference call will be available two hours after the  View Akebia Therapeutics' (NASDAQ:AKBA) earnings history, next earnings date and earnings forecasts from top-rated Wall MarketBeat - Stock Market News and Research Tools logo Akebia Therapeutics Earnings Date, Estimates & History (NASDAQ:AKBA) MarketBeat is accredited by the Better Business Bureau. 15 Mar 2019 On December 13, 2018, Akebia Therapeutics issued a press release announcing the completion of its merger with Keryx Biopharmaceuticals. 10 Mar 2020 Akebia Therapeutics (NASDAQ: AKBA) reported fourth quarter 2019 loss of $0.79 per share AKBA stock dipped more than 5% in the pre-market trading session. (NYSE: BA) were up 13% in afternoon hours on Monday. 19 Mar 2020 Real-time trade and investing ideas on Akebia Therapeutics AKBA from the in Akebia Therapeutics Inc now up 34% for the day $AKBA #stocks. 2 the hoarding of consumer spending and more spending after hibernation, 

24 Feb 2020 The institutional investor bought 1.3 million shares of the stock in a After an ongoing check, Akebia Therapeutics Inc. (AKBA) stock is found to 

AKBA News Today (Akebia Therapeutics) | MarketBeat

AKBA | Stock Snapshot - Fidelity Apr 03, 2020 · The options have an exercise price of $7.58 per share, which is equal to the closing price of Akebia's common stock on the grant date. About Akebia TherapeuticsAkebia Therapeutics (AKBA), Inc. is a fully integrated biopharmaceutical company focused on the development and commercialization of therapeutics for people living with kidney disease.